Meningeal ILC2s were activated in an IL-33-dependent mechanism after spinal cord injury (SCI), releasing type-2 cytokines and demonstrating that ILC2s proliferate in response to IL-33 activation [36]. The gene discussed is IL33; the disease is spinal cord injury.